WASHINGTON —The Food and Drug Administration at the end of May issued a public health advisory to alert patients, caregivers and healthcare professionals to switch to hydrofluoroalkane-propelled ...

Aurobindo Pharma receives U.S. FDA approval for a generic asthma inhaler, expanding into complex respiratory therapies.

In her May 2024 letter, Hassan questioned why GSK discontinued Flovent HFA while keeping other brand-name inhalers on the market and capping their prices. GSK's response did not clarify this; instead, ...

The USFDA approval for Aurobindo Pharma's first metered-dose inhaler takes its cumulative ANDA approvals to 596, strengthening its complex product portfolio.

Add Yahoo as a preferred source to see more of our stories on Google. One of the most widely-used asthma and breathing treatments for over 20 years is being taken off the shelves in 2024, potentially ...

Aurobindo Pharma gains USFDA approval for a generic asthma inhaler, marking its entry into complex respiratory therapies.

Flovent, a popular corticosteroid inhaler used to treat asthma, is no longer available. The global manufacturer, Glaxo Smith Kline (GSK), announced in May that the medications — Flovent HFA, a metered ...

Should hydrofluoroalkane (HFA) inhalers be placed at the mouth rather than two finger spaces away? Are spacer devices appropriate for use with HFA inhalers?—BARBARA BRANDT, NP, Boulder, Colo. Even ...

WASHINGTON The Food and Drug Administration today issued a public health advisory to alert patients, caregivers and healthcare professionals to switch to hydrofluoroalkane propelled albuterol inhalers ...

Reviewers examine the consequences of switching to hydrofluoroalkane, which is replacing chlorofluorocarbon, or CFC, as a key ingredient in albuterol inhalers designed to relieve asthma. The FDA has ...

Aurobindo gets USFDA nod for its first metered-dose asthma inhaler, expanding US respiratory portfolio; see launch plans and stock reaction.